SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-116037
Filing Date
2022-11-09
Accepted
2022-11-08 17:43:44
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230057d1_8k.htm   iXBRL 8-K 25444
2 EXHIBIT 99.1 tm2230057d1_ex99-1.htm EX-99.1 75667
6 GRAPHIC tm2230057d1_ex99-1img01.jpg GRAPHIC 6186
  Complete submission text file 0001104659-22-116037.txt   293971

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20221108.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20221108_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20221108_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2230057d1_8k_htm.xml XML 3716
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 221370133
SIC: 2834 Pharmaceutical Preparations